Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Halifax Biomedical’s proprietary radiostereometric analysis (RSA) technology enables ultra-high precision three-dimensional measurement of orthopedic implants, with a reported accuracy up to ±0.05 mm—significantly better than conventional CT. Their system has received FDA clearance as an upgrade to GE Healthcare’s x-ray systems, supporting both clinical research trials for new implants and emerging clinical applications such as evaluation of painful joint replacements or spinal instability. The company partners with major medical device manufacturers like GE Healthcare.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Halifax Biomedical.